Contrast‐induced acute kidney injury following PCI

Abstract

Background Coronary revascularization using percutaneous coronary intervention (PCI) is one of the major treatments for patients with stable coronary artery disease (CAD), with approximately 1.5 million patients undergoing PCI in the United States and Europe every year. An important neglected complication of PCI is contrast-induced acute kidney injury (CI-AKI).

Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis

“…Patients with CHD combined with hyperuricemia have higher incidence of myocardial infarction. The global number of cardiac surgeries or PCI each year is approximately 2 million [28, 29] and one of the most common and serious post-operative complications is AKI. A current meta analysis found that the incidence of AKI after cardiac surgery was 22.3% around the world (95% CI 19.8-25.1) [2].…”

Admission Hyperglycemia Is an Independent Predictor of Acute Kidney Injury in Patients With Acute Myocardial Infarction

“…This is termed 'contrast-induced AKI (CI-AKI)'. 5, [21][22][23] There is a concern about the risk of CI-AKI for patients undergoing coronary angiography and primary PCI for AMI. In the present study, however, both emergency angiography and primary PCI were not associated with AKI in AMI patients.…”

Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention

“…CIN has become the third leading cause of hospital acquired acute renal failure [2]. The risk factors for CIN are pre-existing renal failure, presence of diabetes mellitus (DM), anemia, dehydration, congestive heart failure, advanced age, gender, excess volume of contrast medium used, and simultaneous usage of nephrotoxic drugs [3].…”